Loading...
Thumbnail Image
Publication

Treatment of hidradenitis suppurativa resolves associated hematologic abnormalities

Morss-Walton, Peyton C
Greif, Charlotte
Holcomb, Zachary E
Salian, Prerna
Yankama, Tuyen
Kim, Diana
Porter, Martina L
Kimball, Alexa B
Embargo Expiration Date
Abstract

Hidradenitis suppurativa (HS) is an inflammatory skin condition predominantly affecting females in North America that has been found to be associated with anemia and leukocytosis. While thrombocytosis is not recognized as related to HS, it would be expected in a systemic inflammatory state. Laboratory abnormalities in severe HS patients can prompt unnecessary medical utilization due to concern for malignancy or infection, and we have observed patients undergo bone marrow biopsy unnecessarily. Better characterization of laboratory values can prevent unwarranted concern. We performed an Institutional Review Board-approved retrospective review of HS patients visiting an academic institution in Boston, MA, from 2015 to 2020.

Source

Morss-Walton PC, Greif C, Holcomb ZE, Salian P, Yankama T, Kim D, Porter ML, Kimball AB. Treatment of hidradenitis suppurativa resolves associated hematologic abnormalities. Int J Womens Dermatol. 2022 Mar 25;8(1):e011. doi: 10.1097/JW9.0000000000000011. PMID: 35620032; PMCID: PMC9112385.

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1097/JW9.0000000000000011
PubMed ID
35620032
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
Copyright © 2022 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of Women’s Dermatologic Society. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Attribution 4.0 International